Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia

Xinping Zhou; Wei Lang; Chen Mei; Yanling Ren; Liya Ma; Lingxu Jiang; Li Ye; Gaixiang Xu; Yingwan Luo; Lixia Liu; Shanbo Cao; Jiayue Qin; Hongyan Tong

doi:10.1002/ctm2.1349

Serial monitoring of circulating tumour DNA on clinical outcome in myelodysplastic syndromes and acute myeloid leukaemia

Clin Transl Med. 2023 Jul;13(7):e1349. doi: 10.1002/ctm2.1349.

Authors

Xinping Zhou^{1

2

3

4}, Wei Lang¹, Chen Mei^{1

2

3

4}, Yanling Ren^{1

2

3

4}, Liya Ma^{1

2

3

4}, Lingxu Jiang¹, Li Ye^{1

2

3

4}, Gaixiang Xu^{1

2

3

4}, Yingwan Luo^{1

2

3

4}, Lixia Liu⁵, Shanbo Cao⁵, Jiayue Qin⁵, Hongyan Tong^{1

2

3

4}

Affiliations

¹ Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Zhejiang Provincial Key Laboratory of Hematopoietic Malignancy, Zhejiang University, Hangzhou, China.
³ Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China.
⁴ Zhejiang University Cancer Center, Hangzhou, China.
⁵ Department of Medical Affairs, Acornmed Biotechnology Co., Ltd., Tianjin, China.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Circulating Tumor DNA* / genetics
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / pathology
Myelodysplastic Syndromes* / diagnosis
Myelodysplastic Syndromes* / genetics

Substances

Circulating Tumor DNA